Denmark wanted advice on handling Trump. It turned to Ozempic’s boss. ○
found
a story from Politico EU ✅ › Politico EU
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — reluctantly — into the limelight.